News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,022 Results
Type
Article (69058)
Company Profile (462)
Press Release (700481)
Multimedia
Podcasts (196)
Webinars (31)
Section
Business (199953)
Career Advice (3831)
Deals (35916)
Drug Delivery (158)
Drug Development (85926)
Employer Resources (205)
FDA (17401)
Job Trends (15874)
News (349727)
Policy (35405)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3000)
Academic (1)
Accelerated approval (44)
Adcomms (37)
Allergies (174)
Alliances (50739)
ALS (206)
Alzheimer's disease (1881)
Antibody-drug conjugate (ADC) (414)
Approvals (17637)
Artificial intelligence (682)
Autoimmune disease (246)
Automation (51)
Bankruptcy (360)
Best Places to Work (12348)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (320)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (727)
Cancer (5627)
Cardiovascular disease (501)
Career advice (3291)
Career pathing (46)
CAR-T (331)
CDC (70)
Celiac Disease (2)
Cell therapy (904)
Cervical cancer (42)
Clinical research (73467)
Collaboration (2066)
Company closure (7)
Compensation (1262)
Complete response letters (91)
COVID-19 (2993)
CRISPR (110)
C-suite (1049)
Cystic fibrosis (160)
Data (7237)
Decentralized trials (3)
Denatured (70)
Depression (176)
Dermatology (59)
Diabetes (588)
Diagnostics (7201)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (331)
Drug pricing (236)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (82247)
Editorial (71)
Employer branding (25)
Employer resources (174)
Events (124569)
Executive appointments (1092)
FDA (20949)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (31)
Funding (1721)
Gene editing (237)
Generative AI (65)
Gene therapy (750)
GLP-1 (1197)
Government (5381)
Grass and pollen (8)
Guidances (399)
Healthcare (20639)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (325)
Immuno-oncology (92)
Indications (158)
Infectious disease (3338)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (282)
Interviews (747)
IPO (16989)
IRA (61)
Job creations (3886)
Job search strategy (2650)
JPM (72)
Kidney cancer (19)
Labor market (104)
Layoffs (642)
Leadership (45)
Legal (8414)
Liver cancer (106)
Longevity (29)
Lung cancer (757)
Lymphoma (416)
Machine learning (54)
Management (66)
Manufacturing (995)
MASH (193)
Medical device (14596)
Medtech (14679)
Mergers & acquisitions (20127)
Metabolic disorders (1582)
mRNA (215)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (437)
Neuropsychiatric disorders (116)
Neuroscience (3405)
Neurotech (2)
NextGen: Class of 2026 (7436)
Non-profit (5062)
Now hiring (62)
Obesity (776)
Opinion (355)
Ovarian cancer (189)
Pain (249)
Pancreatic cancer (266)
Parkinson's disease (364)
Partnered (35)
Patents (577)
Patient recruitment (618)
Peanut (65)
People (60845)
Pharmaceutical (84)
Pharmacy benefit managers (36)
Phase 1 (22919)
Phase 2 (32159)
Phase 3 (24217)
Pipeline (7305)
Policy (367)
Postmarket research (2811)
Preclinical (9847)
Press Release (71)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (330)
Rare diseases (1115)
Real estate (6243)
Recruiting (81)
Regulatory (26910)
Reports (70)
Research institute (2713)
Resumes & cover letters (595)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (178)
Series A (289)
Series B (214)
Service/supplier (12)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (52)
Startups (3806)
State (2)
Stomach cancer (21)
Supply chain (128)
Tariffs (101)
The Weekly (123)
Vaccines (1216)
Venture capital (111)
Weight loss (528)
Women's health (114)
Worklife (23)
Date
Today (11)
Last 7 days (680)
Last 30 days (2569)
Last 365 days (31672)
2026 (8465)
2025 (32009)
2024 (37068)
2023 (41834)
2022 (53134)
2021 (57918)
2020 (56713)
2019 (50352)
2018 (38268)
2017 (35340)
2016 (35246)
2015 (40533)
2014 (33129)
2013 (30702)
2012 (30189)
2011 (30562)
2010 (28363)
Location
Africa (1105)
Alabama (97)
Alaska (7)
Arizona (296)
Arkansas (15)
Asia (45818)
Australia (8016)
California (12485)
Canada (3568)
China (1324)
Colorado (530)
Connecticut (552)
Delaware (372)
Europe (105796)
Florida (1880)
Georgia (408)
Hawaii (3)
Idaho (66)
Illinois (1027)
India (84)
Indiana (561)
Iowa (24)
Japan (500)
Kansas (134)
Kentucky (48)
Louisiana (42)
Maine (85)
Maryland (1536)
Massachusetts (9169)
Michigan (383)
Minnesota (694)
Mississippi (7)
Missouri (145)
Montana (37)
Nebraska (29)
Nevada (140)
New Hampshire (89)
New Jersey (3384)
New Mexico (33)
New York (3327)
North Carolina (1680)
North Dakota (9)
Northern California (6107)
Ohio (390)
Oklahoma (25)
Oregon (45)
Pennsylvania (2513)
Puerto Rico (27)
Rhode Island (51)
South America (1443)
South Carolina (76)
South Dakota (1)
Southern California (4919)
Tennessee (194)
Texas (1994)
United States (44882)
Utah (377)
Vermont (1)
Virginia (312)
Washington D.C. (84)
Washington State (1038)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
770,022 Results for "be the match biotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
Strengthens iSpecimen’s next-generation marketplace platform
March 13, 2026
·
4 min read
Rare diseases
As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question whether they will be enough to net their developers a significant share of the entrenched market.
December 1, 2025
·
5 min read
·
Ben Hargreaves
Press Releases
Animate Biosciences’ Engineered Peptides Match or Exceed Standard Therapy in Preclinical Lung Fibrosis Models
January 14, 2026
·
3 min read
Press Releases
AABB Releases New Exam Prep Bundles For its Certified Advanced Biotherapies Professional (CABP) Credentialing Program
March 26, 2026
·
1 min read
BioMidwest
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport, a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, announced a new strategic partnership.
October 9, 2023
·
4 min read
BioMidwest
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, announced the formation of the Be The Match BioTherapies Cord Blood Bank Alliance.
July 10, 2023
·
3 min read
HIV
Gilead, Merck Clear Path to Market for Daily HIV Pills With New Late-Stage Data
At the 2026 Conference on Retroviruses and Opportunistic Infections, Gilead and Merck demonstrated that their respective daily oral HIV drugs can match current therapies in keeping the virus at bay.
February 26, 2026
·
2 min read
·
Tristan Manalac
BioMidwest
NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development
NMDP BioTherapies ℠, formerly Be The Match BioTherapies unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its rapid-delivery, standard GMP leukopak to simplify regulatory filings.
April 16, 2024
·
4 min read
BioMidwest
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
The National Marrow Donor Program® /Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving the way to successful cell therapy clinical trials with a comprehensive approach and patient support,” to mark Clinical Trials Day 2023.
May 17, 2023
·
6 min read
BioMidwest
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
NMDP BioTherapies℠ (formerly known as Be The Match BioTherapies) will present a poster at this year’s International Society for Cell & Gene Therapy annual meeting in Vancouver, Canada (ISCT 2024 ) sharing results of a study of the impacts of delayed whole blood processing on the stability of infectious disease marker analytes during donor qualification for allogeneic cell therapies.
May 28, 2024
·
3 min read
1 of 77,003
Next
